• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Pharmaceutical Focus: A Look at Combination Products

    The Printed World: Additive Manufacturing in Medtech

    The Lost Year: 2020 Year in Review

    Extrusion Evolution

    Little Big Parts: Micromolding Under the Microscope
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Top News
    Cretex Companies CEO Steps Down

    Data Show Porex's Medical Device Filtration Materials Protect Against Virus, Bacteria Spread

    Endoscopic Hemostasis Devices Market Valued at $730 Million

    Henry Schein Buys Majority Interest in Prism Medical Products

    Boston Scientific's Vercise Genus DBS Earns FDA Approval
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Pharmaceutical Focus: A Look at Combination Products

    The Printed World: Additive Manufacturing in Medtech

    The Lost Year: 2020 Year in Review

    Extrusion Evolution

    Little Big Parts: Micromolding Under the Microscope
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Fixing Face Mask Form and Function

    The Heart of the Matter: Trends in Cardiology

    Virtually the Same? The Challenges of Online Conferences

    Digital Health Delivers During a Year for the Ages

    Advanced Technology for Staking and Swaging Medical Plastics
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Spectrum Plastics Group

    Medbio LLC

    PTI Engineered Plastics Inc.

    FUTEK Advanced Sensor Technology Inc.

    Medicoil
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    Meeting Critical Ventilator Product Requirements Amid Pandemic

    Impact of COVID-19 on the Medtech Supply Chain

    Finding the Upside to a Challenging Year

    Preparing Your Design Controls for FDA Approval

    A 'Trial and Error' Approach to Micromolded Parts
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    maxon

    FUTEK Advanced Sensor Technology Inc.

    Medicoil

    MW Life Sciences

    Unicep
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • Podcasts
    • Resources
    • eBook
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Columns

    What’s New with TAVR?

    ...

    What’s New with TAVR?
    Related CONTENT
    • Medtronic Sees Revenue Losses Due to COVID-19 Pandemic
    • Medtronic Releases Evolut Low Risk Bicuspid Study Results
    • Medtronic Launches MedTech Innovation Accelerator in Shanghai
    • New Hybrid Closed-Loop Insulin Pump Proves Hard to Use for Some Patients with Diabetes
    • Study: Medtronic's Antibiotic Envelope Markedly Cuts Risk of Cardiac Device-Related Infection
    Maria Shepherd, President and Founder, Medi-Vantage04.03.19
    Transcatheter aortic valve replacement (TAVR), once the last resort for patients so sick or elderly they were deemed unable to outlive surgical aortic valve replacement performed via open-heart surgery, has now been proven to offer benefits for younger, low-risk patients, based on the findings from two large clinical trials (Table 1). The first was published in The New England Journal of Medicine (Popma, et. al.),1 and the second—the Partner ll trial2—was sponsored by Edwards Lifesciences.


    Table 1: Death and disabling stroke rates in the Partner II trial (at 1 year)2 and the Popma, et. al trial (at 2 years)1.

    Both studies were randomized controlled studies that followed death, disabling stroke, and hospitalization at one- and two-years post-procedure. In the Partner II trial, the rates of death and disabling stroke were 2.9 percent with surgical aortic valve replacement performed via open heart surgery vs. 1 percent with the TAVR procedure. The Popma, et. al. study found death or disabling stroke rates of 6.7 percent with surgical aortic valve replacement vs. 5.3 percent with TAVR at two years.


    Table 2: The difference in the cost of a TAVR procedure when compared to surgical aortic valve replacement.3

    Further, a significant cost argument can be made for TAVR. In the Partner II trial, procedure cost was approximately $20,0003 higher with TAVR than surgical aortic valve replacement performed via open heart surgery. The total cost difference between surgical aortic valve replacement and TAVR, however, show costs were just $2,888 more with XT-TAVR (P=0.014) and $4,155 lower with S3-TAVR (P<0.001). This was due to a reduction in length of stay with TAVR. In addition, follow-up costs were significantly lower with TAVR (between $9,304 and $11,377; P<0.001) than with surgical aortic valve replacement (Table 2). Over the lifetime of the patient, TAVR is projected to lower the total cost of care by an average of $9,000.

    Full disclosure—the trials were sponsored by Edwards Lifesciences and Medtronic plc, the only medical device manufacturers who have obtained regulatory approval or clearance of TAVR valves.

    With traditional surgical aortic valve replacement, the cardiac surgeon removes the diseased valve and sutures in a replacement. The diseased valve is completely removed from the heart. In comparison, Edwards’ valve is compacted onto a balloon catheter. When it reaches the aorta, the physician inflates the balloon to expand the TAVR valve to replace the failing valve of the patient. Medtronic’s TAVR valve, on the other hand, is nitinol based. After transfemoral access, the physician pulls back the sheath, releasing the new valve into place in the aorta.

    Surgical aortic valve replacements have been performed for decades, and in multiple previous studies in intermediate-risk TAVR patients, data demonstrated that complication rates are equivalent or better for TAVR than for intermediate-risk surgical aortic valve replacement patients.4 Cardiac surgeons recognize valves placed during aortic valve replacement procedures will last at least 10 to 15 years. The next step for clinical studies will be to determine if TAVR valves have equivalent or longer lasting survival rates.

    Why This Is Important
    These trial results are a shot in the arm for minimally invasive transcatheter valve procedures, and a shot over the bow for open-heart surgery. Complications have proven to be lower with TAVR for stroke and death compared to surgical aortic valve replacement, and interventional cardiologists believe5 it will transform the standard of care for the majority of patients with deteriorating aortic valves.

    FDA is expected to approve the procedure for patients judged to be low-risk. This means up to 20,000 more patients each year could meet the new guidelines for TAVR. Currently, approximately 60,000 patients diagnosed as intermediate- and high-risk can get the operation (Table 3).


    Table 3: Future eligibility for TAVR and the effect on procedure rates.

    We all know what happens in open-heart surgical procedures like surgical aortic valve replacement. The patient’s chest is cracked, and the heart is stopped to insert a replacement aortic valve. Recovery can take several months, and complication rates are high. In a TAVR procedure, transfemoral access is gained through the groin, the TAVR catheter is introduced, and it is threaded up to the heart—similar to the method to place a stent. The procedure is performed under conscious sedation, and like any interventional procedure without complications, the patient goes home in a few days.

    These results would seem to shift the treatment paradigm toward more patients being prescribed for TAVR. Heart surgeons agree. “If I were a patient, I would choose TAVR,” said Dr. Gilbert Tang, a heart surgeon at the Icahn School of Medicine at Mount Sinai in New York, N.Y., who was not involved in the research.5

    Failure of the aortic valve starts in patients with a hardening of the valve controlling blood flow from the heart to the body. The primary risk factor is age, and there is no cure other than to replace the valve.

    The Medi-Vantage Perspective
    Cardiac surgery of any form is a highly profitable money maker for hospitals; as such, hospital administrators are faced with a dilemma. Should they market TAVR to patients much in the same way as the Intuitive Surgical robotics system has been successfully marketed, or take the financial downside when lower-risk patients start demanding the TAVR procedure? TAVR valves cost more than surgical aortic valve replacement, and insurers are reported to pay the same amount for both procedures,5 so the lonely loser here is the hospital. Edwards Lifesciences and Medtronic aren’t taking that risk and are providing TAVR physician finders on their respective websites. Edwards and Medtronic are enjoying their position as first to market but, in the future, many more heart valves will be coming, and aortic valve prices will drop (by how much is anyone’s guess). In the coming years, medical device price strategy and commercialization strategy research will make or break fast-following aortic valve medical devices. 

    References
    1. http://bit.ly/mpo190401
    2. http://bit.ly/mpo190402
    3. http://bit.ly/mpo190404
    4. http://bit.ly/mpo190405
    5. http://bit.ly/mpo190403

    Maria Shepherd has more than 20 years of leadership experience in medical device/life science marketing in small startups and top-tier companies. After her industry career, including her role as vice president of marketing for Oridion Medical, where she boosted the company valuation prior to its acquisition by Covidien/Medtronic, director of marketing for Philips Medical, and senior management roles at Boston Scientific Corp., she founded Medi-Vantage. Medi-Vantage provides marketing, business strategy, and innovation research for the medical device, diagnostic, and digital health industries. The firm quantitatively and qualitatively sizes and segments opportunities, evaluates new technologies, provides marketing services, and assesses prospective acquisitions. Shepherd has taught marketing and product development courses and is a member of the Aligo Medtech Investment Committee (www.aligo.com). She can be reached at 855-343-3100. Visit her website at www.medi-vantage.com. 
    Related Searches
    • acquisition
    • minimally invasive
    • heart
    • tavr
    Related Knowledge Center
    • Cardiovascular
    Suggested For You
    Medtronic Sees Revenue Losses Due to COVID-19 Pandemic Medtronic Sees Revenue Losses Due to COVID-19 Pandemic
    Medtronic Releases Evolut Low Risk Bicuspid Study Results Medtronic Releases Evolut Low Risk Bicuspid Study Results
    Medtronic Launches MedTech Innovation Accelerator in Shanghai Medtronic Launches MedTech Innovation Accelerator in Shanghai
    New Hybrid Closed-Loop Insulin Pump Proves Hard to Use for Some Patients with Diabetes New Hybrid Closed-Loop Insulin Pump Proves Hard to Use for Some Patients with Diabetes
    Study: Medtronic Study: Medtronic's Antibiotic Envelope Markedly Cuts Risk of Cardiac Device-Related Infection
    Medtronic Medtronic's Covidien Pays $17.5M to Resolve Catheter Kickback Case
    Edwards to Buy Corvia, Mitralign Assets Edwards to Buy Corvia, Mitralign Assets
    Insulet Appoints Venture Fund Executive to its Board of Directors Insulet Appoints Venture Fund Executive to its Board of Directors
    Former Medtronic Chairman & CEO Joins Surgical Theater Former Medtronic Chairman & CEO Joins Surgical Theater's Advisory Board
    Medtronic Medtronic's Resolute DES Platform Gains FDA Nod for Chronic Total Occlusion
    Edwards’ PASCAL Transcatheter System Receives CE Mark Edwards’ PASCAL Transcatheter System Receives CE Mark
    Medtronic Launches Deep Brain Stimulation for Medically-Refractory Epilepsy Medtronic Launches Deep Brain Stimulation for Medically-Refractory Epilepsy
    Medtronic Comments on Revised IN.PACT Post Market Study Data Medtronic Comments on Revised IN.PACT Post Market Study Data
    Medtronic Medtronic's Personalized Closed Loop Insulin Pump System Wins Breakthrough Status
     Baxter Signs Open Data Pledge to Improve Patient Safety Baxter Signs Open Data Pledge to Improve Patient Safety

    Related Columns

    • Cardiovascular
      The Heart of the Matter: Trends in Cardiology

      The Heart of the Matter: Trends in Cardiology

      Of the three major segments of coronary stents, bioabsorbable stents are expected to have the highest growth between now and 2022.
      Maria Shepherd, President and Founder, Medi-Vantage 11.04.20

    • Cardiovascular
      The TAVR Plot Thickens

      The TAVR Plot Thickens

      Transcatheter aortic valve replacement (TAVR) surgery has typically targeted patients considered too risky to undergo open-heart surgery.
      Sam Brusco, Associate Editor 09.06.19

    • Cardiovascular | Diagnostics | Digital Health | Patient Monitoring
      Cardiac Care on the Can

      Cardiac Care on the Can

      ...
      Sam Brusco, Associate Editor 04.03.19


    • Cardiovascular
      15 Years of Consi-stent Medtech Progress

      15 Years of Consi-stent Medtech Progress

      ...
      Sam Brusco, Associate Editor 06.04.18

    • Cardiovascular | Digital Health | Neurological
      The Human Cyborg, Circa 2033

      The Human Cyborg, Circa 2033

      ...
      Michael Barbella, Managing Editor 06.04.18

    • Cardiovascular | Digital Health
      Feeding the Medtech Innovation Pipeline

      Feeding the Medtech Innovation Pipeline

      ...
      Maria Shepherd, President and Founder, Medi-Vantage 01.30.18


    • Cardiovascular | Surgical
      Age of Innovation for Valves

      Age of Innovation for Valves

      ...
      David Novotny, Novella Clinical 09.01.17

    • Cardiovascular | Diagnostics
      Changing Administrations and the Strategy for Value-Based Growth in Medtech

      Changing Administrations and the Strategy for Value-Based Growth in Medtech

      ...
      Maria Shepherd, Medi-Vantage 07.26.17

    • Cardiovascular | Diagnostics | Digital Health | Neurological | Patient Monitoring | Surgical
      Four Common Misperceptions of Accelerated FDA Approval

      Four Common Misperceptions of Accelerated FDA Approval

      ...
      Matthew M. Lowe, Executive Vice President, MasterControl 03.07.17


    • Cardiovascular | Diagnostics | Neurological | Patient Monitoring | R&D & Design | Surgical | Testing
      First in Man

      First in Man

      ...
      Steve Maylish, Chief Commercial Officer, Fusion Biotec 03.07.17

    • Cardiovascular | Contract Manufacturing | Materials | R&D & Design
      Critical Aspects for Medical Textile Implant Manufacturing

      Critical Aspects for Medical Textile Implant Manufacturing

      ...
      Rick Crane, Vice President of Innovation Services Group, J-Pac Medical 10.12.16

    • Cardiovascular | Contract Manufacturing | Materials | Testing
      Sterilization Innovations Lead to New Guidance Document

      Sterilization Innovations Lead to New Guidance Document

      ...
      James A. Dunning, QPC Services 05.06.16


    • Cardiovascular
      The Tortuous Trek Toward True Transparency

      The Tortuous Trek Toward True Transparency

      ...
      Michael Barbella , Managing Editor 03.10.16

    • Cardiovascular

      Greatbatch-Lake Region Medical Merger Complete

      ...
      11.11.15

    • Cardiovascular | Contract Manufacturing | Materials | Molding

      Medtech Supplier Consolidation, the Boeing Way

      ...
      Michael Barbella, Managing Editor 11.11.15


    Trending
    • Portable, Home-Use Device Quickly Measures Inflammation Levels
    • Masimo Earns CE Mark For New Fingertip Pulse Oximeter
    • TPI Partners With Zeiss
    • Top 10 Trends In The Medical Device And Equipment Industry
    • Understanding Food-Grade Vs. Biocompatibility For Medical Device Materials
    Breaking News
    • Cretex Companies CEO Steps Down
    • Data Show Porex's Medical Device Filtration Materials Protect Against Virus, Bacteria Spread
    • Endoscopic Hemostasis Devices Market Valued at $730 Million
    • Henry Schein Buys Majority Interest in Prism Medical Products
    • Boston Scientific's Vercise Genus DBS Earns FDA Approval
    View Breaking News >
    CURRENT ISSUE

    November/December 2020

    • Pharmaceutical Focus: A Look at Combination Products
    • The Printed World: Additive Manufacturing in Medtech
    • The Lost Year: 2020 Year in Review
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    NIH Study Compares Low-Fat, Plant-based to Low-Carb, Animal-Based Diet
    Gadot Positions Mineral Line for Vegan Market
    Nutritfy India to Launch Global Broadcast Channel Covering Nutrition
    Coatings World

    Latest Breaking News From Coatings World

    LINE-X Launches Dealer Program with International Truck
    PPG Reports Q4, Full-year 2020 Financial Results
    BASF Begins Implementing Ralignment of Global Business Services Unit
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Cretex Companies CEO Steps Down
    Data Show Porex's Medical Device Filtration Materials Protect Against Virus, Bacteria Spread
    Endoscopic Hemostasis Devices Market Valued at $730 Million
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Pfizer, BioNTech Enter Vax Pact with COVAX
    FDA Approves Janssen’s CABENUVA
    AGC Biologics Appoints Boulder Site GM
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Coty Appoints Chief Procurement Officer
    Lageen Tubes Launches Mono-Material PE Tube Solutions
    Jason Jones Loses Battle with Covid-19
    Happi

    Latest Breaking News From Happi

    Carol’s Daughter Adds New Hair Products
    Moroccan Gold Series Launches NuDo Shampoo
    Youbody Debuts Waterless Body Wash
    Ink World

    Latest Breaking News From Ink World

    BOBST Demonstrates Future of Flexible Packaging Production at Virtual Open House
    Morancé Soudure France Adds Comexi F2 MC 10-color Flexo Press
    AR Packaging Acquiring Firstan Holdings Ltd
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Gallus planning virtual event for March
    Lemu Group engineers mask-making machine
    Niagara Label upgrades with Nilpeter flexo press
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Freudenberg to Establish Apparel Interlining Competence Centers
    Minet Adds Spunlace Line in Romania
    Lemu Group Engineers Mask-Making Machine
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Cretex Companies CEO Steps Down
    Conformis Enters Development & Supply Agreement with SITES Medical
    Sectra, RSA Biomedical Sign Distribution Agreement for Implant Stability Tool
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    UDC Subsidiary Adesis' Website Wins 2020 MarCom Platinum Award
    Ambiq Wins IoT Semiconductor Company of the Year Award
    Ynvisible Names Michael Robinson CEO, Jani-Mikael Kuusisto SVP Ventures

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login